Oncology Pharmacogenetics (PGx) Gene Variation Panel
Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
Cancer Antigen (CA) 19-9, Serum
Inhibitor Screen (1:1 Mix), Mixing Studies
MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
The BT-Reveal Early Pancreatic Cancer Test
Peripheral T-cell lymphoma
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Cancer Antigen (CA) 19-9, Serum
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Cancer Antigen (CA) 19-9, Serum
Medical Test
Methodology
Access to
Cancer Antigen (CA) 19-9, Serum
is restricted.
Sign up now
Loading...